United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.
United Therapeutics Corporation (NASDAQ : UTHR ) ("United Therapeutics") today announced that it has closed the merger of SteadyMed Ltd. (NASDAQ : STDY ) ("SteadyMed") with a subsidiary of United Therapeutics. Pursuant to the merger, United Therapeutics acquired all of the outstanding ordinary shares of SteadyMed. As a result of the merger, SteadyMed ordinary shares are no longer publicly traded on the NASDAQ Stock Market.
About United Therapeutics
United Therapeutics is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions.